Stefan Buk

1.1k total citations
13 papers, 543 citations indexed

About

Stefan Buk is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Stefan Buk has authored 13 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Rheumatology. Recurrent topics in Stefan Buk's work include Ion channel regulation and function (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Stefan Buk is often cited by papers focused on Ion channel regulation and function (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Stefan Buk collaborates with scholars based in United Kingdom, United States and Australia. Stefan Buk's co-authors include C. W. M. Adams, Robin N. Poston, Heinz Jungbluth, Safa Al‐Sarraj, Elizabeth Wraige, Caroline A. Sewry, Stephen Abbs, Haiyan Zhou, Suzanne Lillis and M I Filipe and has published in prestigious journals such as Journal of Clinical Pathology, Journal of the Neurological Sciences and Neuropathology and Applied Neurobiology.

In The Last Decade

Stefan Buk

12 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Buk United Kingdom 10 264 163 108 100 63 13 543
Karolina Hankiewicz Spain 9 214 0.8× 142 0.9× 106 1.0× 98 1.0× 15 0.2× 14 391
Shin Fujimoto Japan 16 232 0.9× 70 0.4× 100 0.9× 148 1.5× 54 0.9× 32 670
A.C. Bird United Kingdom 17 557 2.1× 128 0.8× 43 0.4× 113 1.1× 49 0.8× 43 1.1k
Hans‐Hilmar Goebel Germany 17 375 1.4× 53 0.3× 60 0.6× 111 1.1× 91 1.4× 44 769
G. Cole United Kingdom 13 167 0.6× 70 0.4× 21 0.2× 90 0.9× 36 0.6× 21 508
Anke Hensiek United Kingdom 12 178 0.7× 297 1.8× 55 0.5× 104 1.0× 16 0.3× 27 669
Hacer Durmuş Türkiye 15 183 0.7× 63 0.4× 31 0.3× 327 3.3× 79 1.3× 49 594
Andrew Norman United Kingdom 17 444 1.7× 38 0.2× 65 0.6× 55 0.6× 110 1.7× 30 825
Jodi L. Klessner United States 6 203 0.8× 54 0.3× 43 0.4× 42 0.4× 120 1.9× 6 390
David D. Pfaffenbach United States 9 183 0.7× 167 1.0× 25 0.2× 128 1.3× 29 0.5× 11 657

Countries citing papers authored by Stefan Buk

Since Specialization
Citations

This map shows the geographic impact of Stefan Buk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Buk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Buk more than expected).

Fields of papers citing papers by Stefan Buk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Buk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Buk. The network helps show where Stefan Buk may publish in the future.

Co-authorship network of co-authors of Stefan Buk

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Buk. A scholar is included among the top collaborators of Stefan Buk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Buk. Stefan Buk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Dlamini, Nomazulu, Dragana Josifova, Simon Paine, et al.. (2013). Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene. Neuromuscular Disorders. 23(5). 391–398. 40 indexed citations
3.
Dowling, James J., Suzanne Lillis, Haiyan Zhou, et al.. (2011). King–Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscular Disorders. 21(6). 420–427. 72 indexed citations
4.
Forrest, Katharine, Safa Al‐Sarraj, C. Sewry, et al.. (2010). Infantile onset myofibrillar myopathy due to recessive CRYAB mutations. Neuromuscular Disorders. 21(1). 37–40. 36 indexed citations
5.
Zhou, Haiyan, Suzanne Lillis, Ryan E. Loy, et al.. (2010). Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscular Disorders. 20(3). 166–173. 64 indexed citations
6.
Forrest, Katharine, Jemima E. Mellerio, S. Robb, et al.. (2010). Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin. Neuromuscular Disorders. 20(11). 709–711. 30 indexed citations
7.
Keen, C. E., et al.. (1994). Fat necrosis presenting as obscure abdominal mass: birefringent saponified fatty acid crystalloids as a clue to diagnosis.. Journal of Clinical Pathology. 47(11). 1028–1031. 5 indexed citations
8.
Adams, C. W. M., et al.. (1989). PERLS‘ FERROCYANIDE TEST FOR IRON IN THE DIAGNOSIS OF VASCULITIC NEUROPATHY. Neuropathology and Applied Neurobiology. 15(5). 433–439. 13 indexed citations
9.
Adams, C. W. M., Robin N. Poston, & Stefan Buk. (1989). Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. Journal of the Neurological Sciences. 92(2-3). 291–306. 137 indexed citations
10.
Buk, Stefan, et al.. (1986). Periodate oxidation of glycolipids: A borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections. The Histochemical Journal. 18(5). 228–232. 1 indexed citations
11.
12.
Adams, C. W. M., et al.. (1985). Inflammatory vasculitis in multiple sclerosis. Journal of the Neurological Sciences. 69(3). 269–283. 107 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karolina Hankiewicz Breakdown of academic impact, for papers by Shin Fujimoto Breakdown of academic impact, for papers by A.C. Bird Breakdown of academic impact, for papers by Hans‐Hilmar Goebel Breakdown of academic impact, for papers by G. Cole Breakdown of academic impact, for papers by Anke Hensiek Breakdown of academic impact, for papers by Hacer Durmuş Breakdown of academic impact, for papers by Andrew Norman Breakdown of academic impact, for papers by Jodi L. Klessner Breakdown of academic impact, for papers by David D. Pfaffenbach
Rankless by CCL
2026